| Institution: | 1. Dermatology, Ghent University Hospital, Ghent, Belgium;2. Dermatology, Centre Hospitalier Universitaire de Liège, Liège, Belgium;3. Dermatology, Cliniques Saint-Luc, Université Catholique de Louvain, Brussels, Belgium;4. Dermatology, University Hospital Leuven, Leuven, Belgium;5. Dermatology, University Hospital of Antwerp, Antwerp, Belgium;6. Private Practice, Tremelo, Belgium;7. Dermatology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium;8. Funding sources
The research has been performed with own resources. Logistical support during meetings with key opinion leaders was provided by Novartis Belgium who did not intervene in the study's design, progress and outcomes. |
